Search research articles
Contact Us
Filters
Showing results (541-550 of 553) with videos related to
Page
of 56
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases
|
January 15, 2020
A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience
Vincenzo De Sanctis, Ashraf T Soliman, Shahina Daar, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
May 15, 2026
A Descriptive Preanalytical Survey of Procedures Followed for the Screening of Glucose Dysregulation in Thalassemia Centers: Implications for Clinical Practice and Call for Harmonization
Vincenzo de Sanctis, Shahina Daar, Ploutarchos Tzoulis, et al.
The European Respiratory Journal
|
May 28, 2016
Digital health for the End TB Strategy: developing priority products and making them work
Dennis Falzon, Hazim Timimi, Pascal Kurosinski, et al.
Acta Bio-Medica : Atenei Parmensis
|
September 14, 2020
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand
Vincenzo De Sanctis, Duran Canatan, Joan Lluis Vives Corrons, et al.
ACS Pharmacology & Translational Science
|
June 19, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction
Perihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, et al.
European Journal of Medicinal Chemistry
|
May 26, 2026
One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction
Nayera W Hassan, Ola S Afifi, Maryam A Z El-Attar, et al.
Acta Bio-Medica : Atenei Parmensis
|
January 20, 2018
An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary report
Vincenzo De Sanctis, Ashraf T Soliman, Duran Canatan, et al.
Acta Bio-Medica : Atenei Parmensis
|
January 19, 2019
An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations
Vincenzo De Sanctis, Ashraf T Soliman, Duran Canatan, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
January 20, 2025
A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization
Vincenzo de Sanctis, Duran Canatan, Shahina Daar, et al.
Heliyon
|
April 25, 2022
Stigma towards health care providers taking care of COVID-19 patients: A multi-country study
Abdulqadir J Nashwan, Glenn Ford D Valdez, Sadeq Al-Fayyadh, et al.
Page
of 56
Search research articles
Search
Showing results (541-550 of 553) with videos related to
Sort By:
Page
of 56
Mediterranean Journal of Hematology and Infectious Diseases
|
January 15, 2020
A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience
Vincenzo De Sanctis, Ashraf T Soliman, Shahina Daar, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
May 15, 2026
A Descriptive Preanalytical Survey of Procedures Followed for the Screening of Glucose Dysregulation in Thalassemia Centers: Implications for Clinical Practice and Call for Harmonization
Vincenzo de Sanctis, Shahina Daar, Ploutarchos Tzoulis, et al.
The European Respiratory Journal
|
May 28, 2016
Digital health for the End TB Strategy: developing priority products and making them work
Dennis Falzon, Hazim Timimi, Pascal Kurosinski, et al.
Acta Bio-Medica : Atenei Parmensis
|
September 14, 2020
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand
Vincenzo De Sanctis, Duran Canatan, Joan Lluis Vives Corrons, et al.
ACS Pharmacology & Translational Science
|
June 19, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction
Perihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, et al.
European Journal of Medicinal Chemistry
|
May 26, 2026
One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction
Nayera W Hassan, Ola S Afifi, Maryam A Z El-Attar, et al.
Acta Bio-Medica : Atenei Parmensis
|
January 20, 2018
An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary report
Vincenzo De Sanctis, Ashraf T Soliman, Duran Canatan, et al.
Acta Bio-Medica : Atenei Parmensis
|
January 19, 2019
An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations
Vincenzo De Sanctis, Ashraf T Soliman, Duran Canatan, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
January 20, 2025
A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization
Vincenzo de Sanctis, Duran Canatan, Shahina Daar, et al.
Heliyon
|
April 25, 2022
Stigma towards health care providers taking care of COVID-19 patients: A multi-country study
Abdulqadir J Nashwan, Glenn Ford D Valdez, Sadeq Al-Fayyadh, et al.
Page
of 56